# A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

> **NCT00338273** · PHASE3 · WITHDRAWN · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.**

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00338273
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-12
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00338273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00338273, "A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00338273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*